FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069435 [Registered on: 25/06/2024] Trial Registered Prospectively
Last Modified On: 24/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare the effects of lignocaine given as nebulization with intravenous lignocaine for decreasing of stress response to laryngoscopy and intubation in patients posted for elective general anaesthesia.  
Scientific Title of Study   A comparative study of lignocaine nebulization with intravenous lignocaine for attenuation of pressor response to laryngoscopy and intubation 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Hublikar Hemanth 
Designation  Postgraduate student 
Affiliation  Mysore Medical College and Research Institute 
Address  First floor, New stone building, Department of Anaesthesiology,Mysore Medical College and Research Institute, Irwin road, next to railway station, Mysuru, Karnataka Mysore

Mysore
KARNATAKA
570001
India 
Phone  9731543812  
Fax    
Email  hemanth96.hublikar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sudarshan M B 
Designation  Associate professor.  
Affiliation  Mysore Medical College and Research Institute 
Address  First floor, News Stone building, Department of Anaesthesiology, Mysore medical college and Research Institute, Irwin road, next to railway station, Mysuru, Karnataka Mysore

Mysore
KARNATAKA
570001
India 
Phone  9900262710  
Fax    
Email  drmbs1975@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Sudarshan M B 
Designation  Associate professor.  
Affiliation  Mysore Medical College and Research Institute 
Address  First floor, New stone building, Department of Anaesthesiology, Mysore medical college and Research Institute, Irwin road, next to railway station, Mysuru, Karnataka Mysore

Mysore
KARNATAKA
570001
India 
Phone  9900262710  
Fax    
Email  drmbs1975@yahoo.com  
 
Source of Monetary or Material Support  
Mysore medical college and research Institute, Irwin road, Mysore, Karnataka, India- 570001. 
 
Primary Sponsor  
Name  Hublikar Hemanth 
Address  Mysore medical college and Research Institute, Irwin road, next to railway station, mysore, 570001 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Hublikar Hemanth  Mysore medical college  Operation Theatre, Department of Anaesthesiology, first floor, New stone building, KR hospital Mysore.
Mysore
KARNATAKA 
9731543812

hemanth96.hublikar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee, Mysore medical college and research Institute and associated hospitals.   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Comparison between nebulized lignocaine and Intravenous lignocaine in attenuation of intubation response.  Comparing effects of nebulized lignocaine(2mg/kg) and intravenous lignocaine(2mg/kg) given once prior to intubation in attenuation of stress response in patients undergoing General anesthesia posted for elective surgeries . Patient is observed for a period of about 15 minutes post intubation.  
Intervention  Two Different routes(Nebulization and intravenous) of Lignocaine 2% is used prior to laryngoscopy and intubation  Lignocaine 2% 2mg/kg dose is used in two different routes intravenous and nebulization once prior to laryngoscopy and intubation to know its effects for about 15 minutes post intubation 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  All ASA 1 and 2 patients between 18-65 years posted for elective surgeries under general anesthesia.  
 
ExclusionCriteria 
Details  1) ASA grade 3 and 4.
2) Diabetic and Hypertensive patients.
3) known history of drug allergy.
4) Pregnant and lactating women.
5) Chronic respiratory and cardiovascular disease.  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study and compare the effects of intravenous lignocaine IV 2% (2mg/kg) with nebulization of 2% lignocaine (2 mg/kg) on hemodynamic response to laryngoscopy and endotracheal intubation.   From shifting on OT table till 15 minutes post endotracheal intubation 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate any side effects with use of this drug in both routes  Baseline 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "100"
Final Enrollment numbers achieved (India)="100" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   05/07/2024 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a prospective randomised controlled study to compare the effects of Nebulization Of lignocaine 2% with Intravenous lignocaine 2% in attenuation of response to laryngoscopy and endotracheal intubation. Sample size is 100. Patients posted for elective surgeries under General anaesthesia are randomly divided into two groups, 50 receiving Nebulization of lignocaine and 50 receiving Intravenous lignocaine prior to intubation . Hemodynamic response are recorded in those patients and effects are compared.  
Close